Philly’s Tax on Sugary Drinks Did Not Trim Kids’ Obesity
‘Weight is multifactorial,’ researcher noted
Related Articles
Bedaquiline Monotherapy for Multibacillary Leprosy | NEJM
Standard multidrug therapy for leprosy may be associated with severe side effects, which add to the stigma and discrimination that affect persons with the disease.…
Intratracheal Budesonide Mixed With Surfactant for Extremely Preterm Infants
This randomized trial assesses the effect of intratracheal budesonide mixed with surfactant on survival free of bronchopulmonary dysplasia in extremely preterm infants.
Fast-Acting Sub-Perception Therapy Spinal Cord Stimulation Reduces Back Pain
FRIDAY, Dec. 6, 2024 (HealthDay News) — Patients with chronic pain treated with the novel Fast-Acting Sub-Perception Therapy (FAST) spinal cord stimulation (SC
Is mitochondrial morphology important for cellular physiology?
Mitochondria are double membrane-bound organelles the network morphology of which in cells is shaped by opposing events of fusion and fission executed by dynamin-like GTPases.…
Updates in non-neoplastic orthopaedic pathology: what you don’t know can hurt you!
Even though the average surgical pathologist reviews far more non-neoplastic orthopaedic pathology on a daily basis, most current research focuses on rare tumours and their…
Concerns Raised as Too Few U.S. Children Have Received Flu Vaccine
THURSDAY, Dec. 12, 2024 (HealthDay News) — In new data posted this week by the U.S. Centers for Disease Control and Prevention, only 37 percent…
Wall Street wags say a bill to force insurers or PBMs to sell pharmacies has low odds
A proposed Senate bill that would prohibit companies that control health insurers or pharmacy benefit managers from owning pharmacies rattled investors on
A Killing Touches Off Backlash Against Health Insurers – KFF Health News
The shocking shooting death of UnitedHealthcare’s chief executive in Midtown Manhattan prompted a public outcry about the problems with the nation’s health care system, as…
FDA: Ocaliva Linked to Severe Liver Injury in PBC Patients Without Cirrhosis
A higher risk of liver transplant and death was observed in Ocaliva-treated patients vs those who received placebo.
The Coming Wave of New Obesity-Treatment Drugs
Results from dozens of trials are due as drugmakers seek medicines that spur greater weight loss, can be taken less often or cause fewer side…
